Nine pharmaceutical companies signed a price agreement with Trump to avoid tariffs. These include Roche, Merck, Bristol Myers Squibb, GSK, Novartis, Gilead Sciences, Amgen, Sanofi, AbbVie, Johnson &amp; Johnson, and Regeneron Pharmaceuticals have not yet announced an agreement with Trump.
Risk Warning and Disclaimer
The market has risks, and investment should be cautious. This article does not constitute personal investment advice and does not take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment based on this is at one's own risk

GILD

AMGN

Nine pharmaceutical companies signed price agreements with Trump to avoid tariffs, including Roche, Merck, Bristol Myers Squibb, GSK, Novartis, Gilead Sciences, Amgen, and Sanofi. AbbVie, Johnson & Johnson, and Regeneron Pharmaceuticals have not yet announced agreements

Wallstreetcn

Bristol Myers Squibb

Gilead Sciences

Amgen

Nine pharmaceutical companies signed price agreements with Trump to avoid tariffs. These include Roche, Merck, Bristol Myers Squibb, GSK, Novartis, Gilead Sciences, Amgen, Sanofi, AbbVie, Johnson & Johnson, and Regeneron Pharmaceuticals have not yet announced agreements with Trump